HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Tuca Selected Research

Pain (Aches)

9/2009An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Tuca Research Topics

Disease

1Cancer Pain
09/2009
1Pain (Aches)
09/2009
1Breakthrough Pain
09/2009

Drug/Important Bio-Agent (IBA)

1Opioid Analgesics (Opioids)IBA
09/2009
1Delayed-Action PreparationsIBA
09/2009
1Hydromorphone (Dilaudid)FDA LinkGeneric
09/2009
1Morphine (MS Contin)FDA LinkGeneric
09/2009

Therapy/Procedure

1Analgesia
09/2009